{
"info": {
"nct_id": "NCT00057876",
"official_title": "A Randomized Phase III Study Of Gemcitabine In Combination With Radiation Therapy Versus Gemcitabine Alone In Patients With Localized, Unresectable Pancreatic Cancer",
"inclusion_criteria": "* Histologically or cytologically confirmed adenocarcinoma of the pancreas\n\n * Locally advanced or regional (encompassable within the same radiotherapy portals)\n * Adenosquamous cancers are allowed\n* Unresectable disease\n* Measurable and/or non-measurable disease as determined by computed tomography (CT) scan or magnetic resonance imaging (MRI), which must be performed within 4 weeks prior to randomization.\n* Age>=18\n* ECOG Performance status of 0-1\n* Life expectancy >= 12 weeks\n* Adequate bone marrow reserve,liver and renal function within 2 weeks of randomization:\n\n * Absolute granulocyte count at least 2,000/mm^3\n * Platelet count at least 100,000/mm^3\n * Bilirubin less than 3 mg/dL (unless secondary to biliary obstruction or cholangitis)\n * Serum glutamic-oxaloacetic (AST) less than 5 times upper limit of normal (ULN)\n * Albumin greater than 2.5 g/dL\n * Creatinine no greater than 1.5 times ULN\n* Fertile patients must use effective contraception\n* Willing and able to attend follow-up visits\n* Concurrent enrollment on protocol ECOG-E1Y03 allowed\n* More than 4 weeks since prior investigational agents\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Candidate for surgical excision based on local extent of disease (e.g., T3, N1, M0)\n* Stage M1 disease\n* Small cell, mucinous cystadenocarcinoma, islet cell or papillary cystic histology\n* Pregnant or nursing\n* Active infection within within 4 weeks of randomization\n* Malignancy within the past 5 years except nonmelanoma skin cancer, carcinoma in situ of the cervix, or organ-confined prostate cancer (Gleason score no greater than 7)\n* History of active collagen vascular disease (i.e., systemic lupus erythematosus, rheumatoid arthritis, or scleroderma)\n* Signs or symptoms of peptic or duodenal ulcer disease\n* Concurrent serious systemic disorders that are incompatible with study participation\n* Prior chemotherapy for pancreatic cancer\n* Prior radiotherapy\n* Concurrent intensity modulated radiotherapy",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically or cytologically confirmed adenocarcinoma of the pancreas",
"criterions": [
{
"exact_snippets": "Histologically or cytologically confirmed adenocarcinoma of the pancreas",
"criterion": "adenocarcinoma of the pancreas",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
}
]
},
{
"line": "* Locally advanced or regional (encompassable within the same radiotherapy portals)",
"criterions": [
{
"exact_snippets": "Locally advanced or regional",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced",
"regional"
]
}
]
},
{
"exact_snippets": "encompassable within the same radiotherapy portals",
"criterion": "radiotherapy portal suitability",
"requirements": [
{
"requirement_type": "suitability",
"expected_value": true
}
]
}
]
},
{
"line": "* Adenosquamous cancers are allowed",
"criterions": [
{
"exact_snippets": "Adenosquamous cancers are allowed",
"criterion": "adenosquamous cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Unresectable disease",
"criterions": [
{
"exact_snippets": "Unresectable disease",
"criterion": "disease resectability",
"requirements": [
{
"requirement_type": "resectability",
"expected_value": false
}
]
}
]
},
{
"line": "* Measurable and/or non-measurable disease as determined by computed tomography (CT) scan or magnetic resonance imaging (MRI), which must be performed within 4 weeks prior to randomization.",
"criterions": [
{
"exact_snippets": "Measurable and/or non-measurable disease",
"criterion": "disease measurability",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"measurable",
"non-measurable"
]
}
]
},
{
"exact_snippets": "determined by computed tomography (CT) scan or magnetic resonance imaging (MRI)",
"criterion": "imaging method",
"requirements": [
{
"requirement_type": "method",
"expected_value": [
"computed tomography (CT) scan",
"magnetic resonance imaging (MRI)"
]
}
]
},
{
"exact_snippets": "performed within 4 weeks prior to randomization",
"criterion": "imaging timing",
"requirements": [
{
"requirement_type": "timing",
"expected_value": {
"operator": "<=",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Age>=18",
"criterions": [
{
"exact_snippets": "Age>=18",
"criterion": "age",
"requirements": [
{
"requirement_type": "age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* ECOG Performance status of 0-1",
"criterions": [
{
"exact_snippets": "ECOG Performance status of 0-1",
"criterion": "ECOG Performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Life expectancy >= 12 weeks",
"criterions": [
{
"exact_snippets": "Life expectancy >= 12 weeks",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 12,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Absolute granulocyte count at least 2,000/mm^3",
"criterions": [
{
"exact_snippets": "Absolute granulocyte count at least 2,000/mm^3",
"criterion": "absolute granulocyte count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 2000,
"unit": "mm^3"
}
}
]
}
]
},
{
"line": "* Platelet count at least 100,000/mm^3",
"criterions": [
{
"exact_snippets": "Platelet count at least 100,000/mm^3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "mm^3"
}
}
]
}
]
},
{
"line": "* Bilirubin less than 3 mg/dL (unless secondary to biliary obstruction or cholangitis)",
"criterions": [
{
"exact_snippets": "Bilirubin less than 3 mg/dL",
"criterion": "bilirubin level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "mg/dL"
}
}
]
},
{
"exact_snippets": "unless secondary to biliary obstruction or cholangitis",
"criterion": "bilirubin level exception",
"requirements": [
{
"requirement_type": "condition",
"expected_value": [
"biliary obstruction",
"cholangitis"
]
}
]
}
]
},
{
"line": "* Serum glutamic-oxaloacetic (AST) less than 5 times upper limit of normal (ULN)",
"criterions": [
{
"exact_snippets": "Serum glutamic-oxaloacetic (AST) less than 5 times upper limit of normal (ULN)",
"criterion": "serum glutamic-oxaloacetic (AST)",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 5,
"unit": "times ULN"
}
}
]
}
]
},
{
"line": "* Albumin greater than 2.5 g/dL",
"criterions": [
{
"exact_snippets": "Albumin greater than 2.5 g/dL",
"criterion": "albumin level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">",
"value": 2.5,
"unit": "g/dL"
}
}
]
}
]
},
{
"line": "* Creatinine no greater than 1.5 times ULN",
"criterions": [
{
"exact_snippets": "Creatinine no greater than 1.5 times ULN",
"criterion": "creatinine level",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "times ULN"
}
}
]
}
]
},
{
"line": "* Fertile patients must use effective contraception",
"criterions": [
{
"exact_snippets": "Fertile patients",
"criterion": "fertility",
"requirements": [
{
"requirement_type": "status",
"expected_value": "fertile"
}
]
},
{
"exact_snippets": "must use effective contraception",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
},
{
"requirement_type": "effectiveness",
"expected_value": "effective"
}
]
}
]
},
{
"line": "* Willing and able to attend follow-up visits",
"criterions": [
{
"exact_snippets": "Willing and able to attend follow-up visits",
"criterion": "attendance at follow-up visits",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
},
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* Concurrent enrollment on protocol ECOG-E1Y03 allowed",
"criterions": [
{
"exact_snippets": "Concurrent enrollment on protocol ECOG-E1Y03 allowed",
"criterion": "enrollment on protocol ECOG-E1Y03",
"requirements": [
{
"requirement_type": "concurrency",
"expected_value": true
}
]
}
]
},
{
"line": "* More than 4 weeks since prior investigational agents",
"criterions": [
{
"exact_snippets": "More than 4 weeks since prior investigational agents",
"criterion": "time since prior investigational agents",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Candidate for surgical excision based on local extent of disease (e.g., T3, N1, M0)",
"criterions": [
{
"exact_snippets": "Candidate for surgical excision",
"criterion": "surgical excision candidacy",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": true
}
]
},
{
"exact_snippets": "local extent of disease (e.g., T3, N1, M0)",
"criterion": "local extent of disease",
"requirements": [
{
"requirement_type": "staging",
"expected_value": [
"T3",
"N1",
"M0"
]
}
]
}
]
},
{
"line": "* Stage M1 disease",
"criterions": [
{
"exact_snippets": "Stage M1 disease",
"criterion": "disease stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "M1"
}
]
}
]
},
{
"line": "* Small cell, mucinous cystadenocarcinoma, islet cell or papillary cystic histology",
"criterions": [
{
"exact_snippets": "Small cell",
"criterion": "histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": "small cell"
}
]
},
{
"exact_snippets": "mucinous cystadenocarcinoma",
"criterion": "histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": "mucinous cystadenocarcinoma"
}
]
},
{
"exact_snippets": "islet cell",
"criterion": "histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": "islet cell"
}
]
},
{
"exact_snippets": "papillary cystic histology",
"criterion": "histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": "papillary cystic"
}
]
}
]
},
{
"line": "* Pregnant or nursing",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "nursing",
"criterion": "nursing",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Active infection within within 4 weeks of randomization",
"criterions": [
{
"exact_snippets": "Active infection within within 4 weeks of randomization",
"criterion": "active infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
},
{
"requirement_type": "time frame",
"expected_value": "within 4 weeks of randomization"
}
]
}
]
},
{
"line": "* Malignancy within the past 5 years except nonmelanoma skin cancer, carcinoma in situ of the cervix, or organ-confined prostate cancer (Gleason score no greater than 7)",
"criterions": [
{
"exact_snippets": "Malignancy within the past 5 years",
"criterion": "malignancy",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
]
},
{
"exact_snippets": "nonmelanoma skin cancer",
"criterion": "nonmelanoma skin cancer",
"requirements": [
{
"requirement_type": "exclusion",
"expected_value": true
}
]
},
{
"exact_snippets": "carcinoma in situ of the cervix",
"criterion": "carcinoma in situ of the cervix",
"requirements": [
{
"requirement_type": "exclusion",
"expected_value": true
}
]
},
{
"exact_snippets": "organ-confined prostate cancer (Gleason score no greater than 7)",
"criterion": "organ-confined prostate cancer",
"requirements": [
{
"requirement_type": "Gleason score",
"expected_value": {
"operator": "<=",
"value": 7,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* History of active collagen vascular disease (i.e., systemic lupus erythematosus, rheumatoid arthritis, or scleroderma)",
"criterions": [
{
"exact_snippets": "History of active collagen vascular disease",
"criterion": "active collagen vascular disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "systemic lupus erythematosus",
"criterion": "systemic lupus erythematosus",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "rheumatoid arthritis",
"criterion": "rheumatoid arthritis",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "scleroderma",
"criterion": "scleroderma",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Signs or symptoms of peptic or duodenal ulcer disease",
"criterions": [
{
"exact_snippets": "Signs or symptoms of peptic or duodenal ulcer disease",
"criterion": "peptic or duodenal ulcer disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Concurrent serious systemic disorders that are incompatible with study participation",
"criterions": [
{
"exact_snippets": "Concurrent serious systemic disorders",
"criterion": "serious systemic disorders",
"requirements": [
{
"requirement_type": "compatibility with study participation",
"expected_value": false
}
]
}
]
},
{
"line": "* Prior chemotherapy for pancreatic cancer",
"criterions": [
{
"exact_snippets": "Prior chemotherapy for pancreatic cancer",
"criterion": "prior chemotherapy",
"requirements": [
{
"requirement_type": "condition",
"expected_value": "pancreatic cancer"
}
]
}
]
},
{
"line": "* Prior radiotherapy",
"criterions": [
{
"exact_snippets": "Prior radiotherapy",
"criterion": "radiotherapy",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": true
}
]
}
]
},
{
"line": "* Concurrent intensity modulated radiotherapy",
"criterions": [
{
"exact_snippets": "Concurrent intensity modulated radiotherapy",
"criterion": "intensity modulated radiotherapy",
"requirements": [
{
"requirement_type": "concurrency",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "* Adequate bone marrow reserve,liver and renal function within 2 weeks of randomization:",
"criterions": [
{
"exact_snippets": "Adequate bone marrow reserve",
"criterion": "bone marrow reserve",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "adequate ... liver ... function",
"criterion": "liver function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "adequate ... renal function",
"criterion": "renal function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}